Nonadherence to antihypertensive medications is related to pill burden in apparent treatment-resistant hypertensive individuals
- PMID: 32371807
- DOI: 10.1097/HJH.0000000000002398
Nonadherence to antihypertensive medications is related to pill burden in apparent treatment-resistant hypertensive individuals
Abstract
Objective: Nonadherence to medication is present in at least 50% of patients with apparent treatment-resistant hypertension. We examined the factors associated with nonadherence as detected by a liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based urine antihypertensive drug assay.
Methods: All urine antihypertensive test results, carried out for uncontrolled hypertension (BP persistently >140/90 mmHg) between January 2015 and December 2016 at a single toxicology laboratory were analysed. Drugs detected were compared with the antihypertensive drugs prescribed. Patients were classified as adherent (all drugs detected), partially nonadherent (at least one prescribed drug detected) or completely nonadherent (no drugs detected). Demographic and clinical parameters were compared between the adherent and nonadherent groups. Binary logistic regression analysis was performed to determine association between nonadherence and demographic and clinical factors.
Results: Data on 300 patients from nine hypertension centres across the United Kingdom were analysed. The median age was 59 years, 47% women, 71% Caucasian, median clinic BP was 176/95 mmHg and the median number of antihypertensive drugs prescribed was four. One hundred and sixty-six (55%) were nonadherent to prescribed medication with 20% of these being completely nonadherent. Nonadherence to antihypertensive medication was independently associated with younger age, female sex, number of antihypertensive drugs prescribed, total number of all medications prescribed (total pill burden) and prescription of a calcium channel blocker.
Conclusion: This LC-MS/MS urine analysis-based study suggests the majority of patients with apparent treatment-resistant hypertension are nonadherent to prescribed treatment. Factors that are associated with nonadherence, particularly pill burden, should be taken into account while treating these patients.
Similar articles
-
Nonadherence to antihypertensive medications amongst patients with uncontrolled hypertension: A retrospective study.Medicine (Baltimore). 2021 Apr 9;100(14):e24654. doi: 10.1097/MD.0000000000024654. Medicine (Baltimore). 2021. PMID: 33832064 Free PMC article.
-
Adherence to antihypertensive medications in Omani patients: a comparison of drug biochemical analysis and the Morisky Medication Adherence Scale.J Hypertens. 2025 Feb 1;43(2):205-210. doi: 10.1097/HJH.0000000000003917. Epub 2024 Nov 2. J Hypertens. 2025. PMID: 39526688
-
Biochemical Screening for Nonadherence Is Associated With Blood Pressure Reduction and Improvement in Adherence.Hypertension. 2017 Nov;70(5):1042-1048. doi: 10.1161/HYPERTENSIONAHA.117.09631. Epub 2017 Aug 28. Hypertension. 2017. PMID: 28847892 Free PMC article.
-
Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing.Hypertension. 2022 Jan;79(1):12-23. doi: 10.1161/HYPERTENSIONAHA.121.17596. Epub 2021 Nov 5. Hypertension. 2022. PMID: 34739765 Review.
-
Adherence to antihypertensive medications: is prescribing the right pill enough?Nephrol Dial Transplant. 2015 Oct;30(10):1649-56. doi: 10.1093/ndt/gfu330. Epub 2014 Oct 21. Nephrol Dial Transplant. 2015. PMID: 25335506 Free PMC article. Review.
Cited by
-
A cross-sectional study on the assessment of adherence to cardiovascular medications in Sudan heart center.PLoS One. 2025 Jan 30;20(1):e0315672. doi: 10.1371/journal.pone.0315672. eCollection 2025. PLoS One. 2025. PMID: 39883671 Free PMC article.
-
Supporting General Practitioners and people with hypertension to maximise medication use to control blood pressure: the contribution of Collective Intelligence to the development of the 'Maximising Adherence, Minimising Inertia' (MIAMI) intervention.Health Psychol Behav Med. 2024 Sep 19;12(1):2404038. doi: 10.1080/21642850.2024.2404038. eCollection 2024. Health Psychol Behav Med. 2024. PMID: 39315072 Free PMC article.
-
Sex differences in arterial hypertension.Eur Heart J. 2022 Dec 7;43(46):4777-4788. doi: 10.1093/eurheartj/ehac470. Eur Heart J. 2022. PMID: 36136303 Free PMC article. Review.
-
[Elevated blood pressure and hypertension : Focus of the 2024 ESC guidelines on risk reduction].Herz. 2025 Feb;50(1):17-24. doi: 10.1007/s00059-024-05285-8. Epub 2024 Nov 26. Herz. 2025. PMID: 39589443 Review. German.
-
Investigation and management of young-onset hypertension: British and Irish hypertension society position statement.J Hum Hypertens. 2024 Jul;38(7):544-554. doi: 10.1038/s41371-024-00922-5. Epub 2024 Jun 28. J Hum Hypertens. 2024. PMID: 38942895 Free PMC article. Review.
References
-
- Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290:199–206.
-
- Cushman WC, Ford CE, Cutler JA, Margolis KL, Davis BR, Grimm RH, et al. ALLHAT Collaborative Research GroupSuccess and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2002; 4:393–404.
-
- Egan BM, Zhao Y, Axon RN, Brzezinski WA, Ferdinand KC. Uncontrolled and apparent treatment resistant hypertension TRHin the United States, 1988 to 2008. Circulation 2011; 124:1046–1058.
-
- Persell SD. Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension 2011; 57:1076–1080.
-
- de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P, et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 2011; 57:898–902.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical